• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢囊腺瘤DNA含量与其病理组织学的关系

[Relation between DNA content in ovarian cystadenoma and its pathohistology].

作者信息

Sun Z C

机构信息

PLA 254 Hospital, Tianjin.

出版信息

Zhonghua Fu Chan Ke Za Zhi. 1993 Dec;28(12):731-3, 760-1.

PMID:8137645
Abstract

DNA index and cell cycle distribution were studied by flow cytometry in 32 cases of ovarian borderline cystadenoma, 16 ovarian cystadenocarcinoma and 12 ovarian benign cystadenoma, and their relations to pathological patterns of the diseases were inquired. The results showed that the DNA index and S+G2M phase in cell cycle of the diseases were related to their pathological patterns. The DNA index and S+G2M cell were increased by turn from benign to borderline and to malignant tumor. DNA index and cell cycle distribution might be valuable in reflecting the biological behavior of deteriorating ovarian cystadenoma. The authors consider that determination of DNA content and cell cycle could be biological indexes of supplementary diagnosis for the deterioration of borderline tumor.

摘要

采用流式细胞术对32例卵巢交界性囊腺瘤、16例卵巢囊腺癌和12例卵巢良性囊腺瘤进行DNA指数及细胞周期分布研究,并探讨其与疾病病理类型的关系。结果显示,这些疾病的DNA指数及细胞周期中的S + G2M期与其病理类型有关。DNA指数及S + G2M细胞从良性肿瘤到交界性肿瘤再到恶性肿瘤依次升高。DNA指数及细胞周期分布可能对反映卵巢囊腺瘤恶变的生物学行为有价值。作者认为,测定DNA含量及细胞周期可作为交界性肿瘤恶变辅助诊断的生物学指标。

相似文献

1
[Relation between DNA content in ovarian cystadenoma and its pathohistology].卵巢囊腺瘤DNA含量与其病理组织学的关系
Zhonghua Fu Chan Ke Za Zhi. 1993 Dec;28(12):731-3, 760-1.
2
[A quantitative study on nuclear DNA content and morphological parameters in ovarian cystadenocarcinoma].卵巢囊腺癌细胞核DNA含量及形态学参数的定量研究
Zhonghua Fu Chan Ke Za Zhi. 1995 Dec;30(12):738-40.
3
[Prognostic significance of cellular DNA content and AgNOR count in ovarian cystadenoma].[卵巢囊腺瘤中细胞DNA含量及核仁组成区嗜银蛋白计数的预后意义]
Ai Zheng. 2003 Jan;22(1):62-5.
4
Flow cytometry and AgNORs in benign, borderline, and malignant mucinous and serous tumours of the ovary.卵巢良性、交界性及恶性黏液性和浆液性肿瘤中的流式细胞术及核仁组成区嗜银蛋白
Int J Gynecol Pathol. 1993 Oct;12(4):307-14. doi: 10.1097/00004347-199310000-00005.
5
KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants.卵巢肿瘤中的KRAS和BRAF突变:对浸润性癌、交界性肿瘤和卵巢外种植体的综合研究
Gynecol Oncol. 2006 Dec;103(3):883-7. doi: 10.1016/j.ygyno.2006.05.029. Epub 2006 Jun 30.
6
A study of the methylation status of opioid binding protein/cell adhesion molecule-like gene in ovarian cancer using nested methylation-specific polymerase chain reaction detection.运用巢式甲基化特异性聚合酶链反应检测技术对卵巢癌中阿片样物质结合蛋白/细胞黏附分子样基因甲基化状态的研究
Clin Lab. 2011;57(5-6):421-4.
7
[Clinical behavior of serous and mucinous borderline tumors of the ovary with diploid DNA stem line. Follow-up studies after organ preserving and non-organ preserving therapy].[具有二倍体DNA干细胞系的卵巢浆液性和黏液性交界性肿瘤的临床行为。保留器官和非保留器官治疗后的随访研究]
Zentralbl Gynakol. 2000;122(5):274-9.
8
Association of decreased mitochondrial DNA content with ovarian cancer progression.线粒体DNA含量降低与卵巢癌进展的关联。
Br J Cancer. 2006 Oct 23;95(8):1087-91. doi: 10.1038/sj.bjc.6603377. Epub 2006 Oct 3.
9
Differential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumors.基质金属蛋白酶-9和金属蛋白酶组织抑制剂-1蛋白及mRNA在上皮性卵巢肿瘤中的差异表达
Gynecol Oncol. 2000 Jun;77(3):369-76. doi: 10.1006/gyno.2000.5806.
10
[Accuracy of frozen section in diagnosis of ovarian tumors].[冰冻切片在卵巢肿瘤诊断中的准确性]
Zhonghua Fu Chan Ke Za Zhi. 1993 Oct;28(10):601-3, 635.